The chemical modification and optimization of biologically active compounds are\nessential steps in the identification of promising lead compounds for drug development. We\npreviously reported the anti-melanogenic activity of 1-(2-cyclohexylmethoxy-6-hydroxy-phenyl)-\n3-(4-hydroxymethyl-phenyl)-propenone (chalcone 21). In this study, we synthesized 21 derivatives\nof chalcone 21 and evaluated their anti-melanogenic activity in alpha -MSH-induced B16F10 cells. (E)-\nN-(4-(3-(2-(Cyclohexylmethoxy)phenyl)-3-oxoprop-1-en-1-yl)phenyl)acetamide (chalcone 21-21)\nexhibited the strongest inhibition of cellular melanin production, with an IC50 value of 0.54Micro M. It\nwas more potent than chalcone 21 and the known anti-melanogenic agents kojic acid and arbutin,\nwhose IC50 values were 4.9, 38.5, and 148.4 Micro M, respectively. Chalcone 21-21 decreased the\nexpression and activity of tyrosinase. It also decreased the expression of TRP1, TRP2 and MITF,\nthe phosphorylation of CREB and ERK1/2, and the transcriptional activity of MITF and CRE. Our\nresults demonstrate that chalcone-21-21 is an effective lead compound with anti-melanogenic\nactivity.
Loading....